Standalone Systems Lead the Live Cell Imaging Market: Versatile and Independent Solutions in High Demand - Growth Trends & Forecasts 2023-2028

Dublin, Sept. 29, 2023 (GLOBE NEWSWIRE) -- The "Live Cell Imaging Market Size & Share Analysis - Growth Trends & Forecasts (2023-2028)" report has been added to's offering.

The Global Live Cell Imaging market is on track for substantial growth, with predictions showing an increase from USD 2.09 billion in 2023 to USD 2.94 billion by 2028, marking an impressive Compound Annual Growth Rate (CAGR) of 7.06% during the forecast period (2023-2028).

Several factors are driving this expansion, including the impact of the COVID-19 pandemic, the rising demand for early COVID-19 diagnosis, the adoption of high-content screening in drug discovery, and technological advancements in live cell imaging.

Key Market Highlights

  1. COVID-19 Pandemic Accelerates Growth: The COVID-19 pandemic disrupted supply chains and affected various industries, including live cell imaging. However, the urgent need for early COVID-19 diagnosis and effective vaccines led to a surge in demand for live cell imaging. Researchers leveraged live-cell-based tests to assess the intracellular function of the SARS-CoV-2 target, Main 3C-like protease. This high-throughput COVID-19 Main Protease (Mpro) screening system significantly impacted the market. The increasing use of live cell imaging equipment for studying the molecular biology of the COVID-19 virus is expected to drive market growth in the coming years.
  2. High-Content Screening in Drug Discovery: Live-cell imaging plays a vital role in high-content screening techniques for drug discovery. It enables the identification of multiple measures of cell physiology, offering valuable insights into cell-based assays. High-content screening has proven effective in understanding the downstream effects of various treatments on cancer cells, evaluating signaling heterogeneity, and estimating cellular responses. This advancement is set to drive the adoption of live cell imaging devices for the development of novel cancer treatments and contribute to overall market growth.
  3. Technological Advancements Drive Adoption: Continuous innovation in live cell imaging products is boosting market growth. Innovations like Leica Microsystems' Leica Nano workflow, a live-cell correlative light and electron microscopy (CLEM) solution, enhance experimental success rates and simplify microscopy integration. Zeiss Group's ZEISS Visioner 1, a digital microscope for live-cell imaging, streamlines the imaging process and increases throughput. These developments are expected to fuel market growth throughout the forecast period.

Market Trends

  1. Standalone Systems Lead the Way: Standalone systems, which can function independently without integration into other hardware, are witnessing significant demand in live cell imaging. These systems are crucial for various research applications and are at the forefront of technology-driven R&D efforts. Their versatility and ability to operate independently make them indispensable for researchers. As advanced standalone systems continue to emerge in the market, this segment is projected to grow steadily.
  2. North America Dominates: North America holds a significant share of the live cell imaging market and is poised to maintain its dominance. The region's substantial patient population, increasing geriatric demographic, and robust investment in research contribute to its market growth. The United States, in particular, stands out due to a high burden of chronic diseases, numerous R&D programs, and the presence of major market players. Strategic initiatives, such as partnerships and collaborations, further bolster the live cell imaging market in North America.

Live Cell Imaging Industry Overview

The live cell imaging market is characterized by strong competition among several players. Companies in this space are actively implementing strategies such as mergers, new product launches, acquisitions, and partnerships to strengthen their market positions.

Some of the key players currently dominating the market include Becton, Dickinson and Company, Zeiss Group, Danaher Corporation, Olympus Corporation, Live Cell Instrument, Nikon Corporation Inc., PerkinElmer Inc., Merck KGaA, Thermo Fisher Scientific Inc., among others.

A selection of companies mentioned in this report includes

  • Becton, Dickinson and Company
  • Zeiss Group
  • Axion BioSystems, Inc
  • Danaher (Leica Microsystems)
  • Olympus Corporation (EVIDENT)
  • LCI (Live Cell Instrument)
  • Nikon Corporation Inc
  • PerkinElmer Inc.
  • Merck KGaA (Sigma- Aldrich Corporation)
  • Thermo Fisher Scientific Inc.
  • Agilent Technologies. Inc.
  • Sartorius AG

For more information about this report visit

About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.


Live Cell Imaging Market Projection Of Cardiovascular Diseases United States 2010 2030

Contact Data